SKB264 Monotherapy in Selected Subjects With Advanced Solid Tumors
Clinical trial NCT05631262 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05631262
- Sponsor
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-30
- Primary completion
- 2026-12-30
- Enrollment
- 321
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.